Kolexia
Lefebvre Thibaud
Pharmacien
Hôpital Louis-Mourier
Colombes, France
82 Activités
100 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Anémie Porphyries Carences en fer Surcharge en fer Drépanocytose Thalassémie Porphyrie aigüe intermittente Anémie par carence en fer Maladie grave

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report.
Molecular genetics and metabolism reports   31 octobre 2023
Quantification of Urine and Plasma Porphyrin Precursors Using LC-MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients.
Clinical chemistry   04 octobre 2023
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica chimica acta; international journal of clinical chemistry   05 août 2023
Porfirias hereditarias en niños
EMC. Pediatria   01 décembre 2022
A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease: A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy of the β-Hemoglobinopathies (Sickle Cell Anemia and β-Thalassemia Major) by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral β-A-T87Q Globin Vector (LentiGlobin BB305 Drug Product)
Essai Clinique (Bluebird)   05 avril 2022
Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection.
Alimentary pharmacology & therapeutics   04 février 2022
Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies.
Metabolites   18 janvier 2022
Givosiran in acute intermittent porphyria: A personalized medicine approach.
Molecular genetics and metabolism   10 janvier 2022
Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients.
Clinical kidney journal   08 décembre 2021
Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay.
Metabolites   23 novembre 2021